Tower Research Capital LLC (Trc) Aura Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,102 shares of AURA stock, worth $24,629. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,102
Previous 2,699
14.93%
Holding current value
$24,629
Previous $24,000
4.17%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
40MCall Options Held
31.6KPut Options Held
29K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$55 Million2.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$38.8 Million0.07% of portfolio
-
Eventide Asset Management, LLC Boston, MA4.08MShares$32.4 Million0.64% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$24.1 Million5.49% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$23.9 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $232M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...